In a study of 100 women with non-specific vaginitis, characterised by a vaginal discharge which was malodorous and pruritic in most cases and caused dyspareunia and dysuria in some, Gardnerella vaginalis was isolated in 460% of patients. When present, G vaginalis was significantly associated with Mycoplasma hominis and Bacteroides species. Isolation of G vaginalis was unrelated to the presenting symptoms. Treatment with povidone-iodine pessaries for two weeks produced no pronounced benefit, either clinically or microbiologically, compared with a placebo. Nevertheless, 68% of all patients followed reported improvement four weeks after the start of treatment.The findings suggest that G vaginalis is one cause of non-specific vaginitis, which is more likely to be seen in women using oral contraceptives and is usually cured spontaneously.
Introduction
A considerable number of young women complain of vaginal symptoms for which Candida species and Trichomonas vaginalis are not responsible. Gardner and Dukes' were the first to suggest that Haemophilus vaginalis (later renamed Corynebacterium vaginale and now called Gardnerella vaginalis) may be the cause. Since then they have been both supported2-5 and opposed&9 in this view. For this study, a symptom-based approach was taken in order to establish a clinical picture for non-specific vaginitis, to determine its relationship to G vaginalis infection, and finally to examine the prognosis by a controlled trial with a broad-spectrum vaginal pessary, povidine-iodine, as the active treatment. 
Results
The study group of 100 women with non-specific vaginitis had a mean age of 25 6 years (range 18-54 years); 82 were single. Forty-two women had been pregnant, 54 were using oral contraception, and 16 were fitted with an intrauterine contraceptive device (IUCD).
The control group of 100 unselected female patients had a mean age of 26-0 years (range 17-50 years); 82 were single. Forty-three had been pregnant, 39 were using oral contraception, and 18 were fitted with an IUCD. There were no ethnic differences between the two groups.
SYMPTOMS
Patients were admitted to the study group on the basis of complaint of vaginal discharge shown not to be associated with trichomoniasis, candidosis, or gonorrhoea. Additional symptoms were an offensive smell (68%) and irritation (55%); dyspareunia was noted by 35% and dysuria by 23%7. The The results of the treatment trial are summarised in table IV. In terms of clinical improvement assessed at four weeks, povidone-iodine pessaries were not significantly better than a placebo (XI = 2 38; P>0*05). In fact, 580o of placebo-treated patients reported improvement, and this tendency to spontaneous cure was supported by the microbiological findings; G vaginalis was eliminated from 62* 5 /o of the placebo-treated group at four weeks compared with 7607 of the povidone-iodinetreated group. This was not significant (x2 = 0x29; P>0-05). Of the 11 patients in whom G vaginalis was isolated at follow up, seven (64%) reported that they were better, two patients reported no change, and two were worse, but one of these had a herpetic infection and the other a yeast infection. may enhance the pathogenicity of G vaginalis by interfering with phagocytosis, which gives importance to its presence in 15 out of 18 patients from whom Bacteroides species were isolated. M hominis alone may be responsible for some cases of non-specific vaginitis.'2 Pheifer et at5 could find no relationship between non-specific vaginitis and Ureaplasma urealyticum or, for that matter, Chlamydia trachomatis.
Our findings in non-specific vaginitis point to G vaginalis as being a co-pathogen, together with M hominis or Bacteroides species or both. Exactly what circumstances favour growth of these organisms in vivo has not been established. The strong association with the presence of Bacteroides species, themselves no more frequent in non-specific vaginitis than in our controls, raises the possibility of anaerobic foci in the environment.
We also examined host factors and confirmed the relationship with oral contraceptives reported by McCormack et al9 but not that with previous pregnancy. Oral contraception was associated not only with a greater likelihood of non-specific vaginitis but also with a much greater likelihood that the presence of G vaginalis would be associated with vaginal symptoms. Thus, the hormonal effects of oral contraceptives on vaginal epithelium may possibly promote the pathogenic potential of G vaginalis probably by enhancing its growth rate.
From our study, G vaginalis vaginitis seems likely to develop in a single woman who is taking an oral contraceptive, and cyclical changes in the vagina may well promote spontaneous resolution. These events may be mediated cytologically, a view supported by microscopical examination of the discharge showing cellular overgrowth by organisms, the 'clue cell' described by Gardner and Dukes.' An anaerobic environment may possibly be promoted by collections of cellular debris within the vagina. Although hormonal factors controlling maturation of vaginal epithelium may play a part, it seems reasonable that behavioural factors affecting vaginal hygiene could also be important in the development of non-specific vaginitis. 
